Food allergies are the most common cause of anaphylaxis (severe allergic reaction) in the paediatric population. Over the last 3 decades the prevalence of food allergies in children such as peanut allergy has doubled in the US and UK. Adrenaline Auto-Injectors (AAIs) are currently the main treatment for anaphylaxis in the community. This can be a life-saving procedure, easing anaphylaxis symptoms and providing time to seek medical assessment. However, prompt recognition of anaphylaxis symptoms as well as correct administration of AAI and awareness of an anaphylaxis management plan are also needed for this treatment to be successful.
Patients and caregivers should receive anaphylaxis management and AAI administration training from a healthcare professional at the time they are prescribed. This will usually be done in the setting of an allergy clinic, at a GP clinic, the emergency department or with the pharmacist.
During the COVID-19 pandemic, we have seen a shift in outpatient appointments, with the majority now being delivered via telemedicine. This is a barrier to effective caregiver education surrounding AAI administration. There is no research currently available to illustrate whether online video conferencing can be an effective method of education for caregivers regarding anaphylaxis management and AAI technique.
This study will examine caregiver knowledge, assess their AAI technique prior to an online education session, and quantify improvement in caregiver AAI technique following online education session